Wednesday, March 31, 2021
Gestalt Diagnostics today announced, that BioReference Laboratories Inc., an OPKO Health company, has selected their digital pathology solution, PathFlow®, to support its pathology business. PathFlow is an enterprise software platform specifically designed to bring the benefits of digital workflow to pathologists and pathology laboratories.
Under the agreement, Gestalt is partnering with Leica Biosciences, which provides whole slide imaging scanners, and MindPeak, which provides integrated AI algorithms within Gestalt's PathFlow. The ability to provide the full cycle of digital pathology to BioReference is an example of the acceleration in the advances of technologies and interoperability that are available for integration directly within the pathologist's workflow.
"Speaking on behalf of our team, we are honored to be the chosen vendor to support BioReference Lab's adoption of digital pathology. We look forward to enabling their pathologists to use innovative workflow and AI tools to support the diagnosis of disease including breast cancer," says Dan Roark, Chief Executive Officer, Gestalt Diagnostics.
"Our ability to partner, and interface, with multiple vendors provides a highly interoperable platform with a simple delivery and user experience, enabling their pathologists to achieve their goals of streamlined, interoperable digital pathology with computer aided diagnostic algorithms. BioReference will be using ER, PR, Ki-67, HER2, and P53 AI algorithms for breast diagnostics integrated directly within our digital platform, PathFlow," says Lisa-Jean Clifford, COO & Chief Strategy Officer, Gestalt Diagnostics.